Noticias de Eulerpool AIM ImmunoTech

AIM ImmunoTech Noticias de Acciones

AIM ImmunoTech es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de AIM ImmunoTech.

• 17 de junio ·

  Yahoo
  AIM ImmunoTech Resumes Trading on NYSE American
• 12 de junio ·

  Yahoo
  AIM ImmunoTech Granted U.S. Patent Covering Methods of Manufacturing Therapeutic dsRNA, Including Ampligen®
• 12 de junio ·

  Yahoo
  AIM ImmunoTech Announces NYSE American Removal of Trading Suspension
• 7 de abril ·

  Yahoo
  AIM ImmunoTech Announces Trading Under the Ticker AIMI on the Pink Open Market
• 4 de abril ·

  Yahoo
  AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal
• 1 de abril ·

  SeekingAlpha
  AIM ImmunoTech Inc. (AIM) Q4 2024 Earnings Call Transcript
• 27 de marzo ·

  Yahoo
  AIM ImmunoTech Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
• 11 de marzo ·

  Yahoo
  AIM ImmunoTech Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
• 28 de febrero ·

  Yahoo
  AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza
• 26 de febrero ·

  Yahoo
  AIM ImmunoTech Announces NYSE American Acceptance of Plan to Regain Listing Compliance